Flunixin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H11F3N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 356IB1O400, chemically known as 3-pyridinecarboxylic acid, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)- but generally known as flunixin, which bears US NIH Compound Identifier 38081. European Medicines Agency schedules Flunixin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07711MIG. The term FLUNIXIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). FLUNIXIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flunixin under HS 29333999 and SITC 51574. As of Q4 2014, FLUNIXIN remains the US FDA Preferred Term for this commodity. Flunixin bears US NLM identifiers UMLS ID C0060502 and NCI Concept Code C65721. SMILES: FC(F)(F)C1C(C(NC2NCCCC2C(=O)O)CCC1)C.